Neural Regeneration Research (Jan 2015)
Short-term use of antiepileptic drugs is neurotoxic to the immature brain
- Yu Liu,
- Xue-ying Wang,
- Dan Li,
- Lin Yang,
- Shao-ping Huang
Affiliations
- Yu Liu
- Xue-ying Wang
- Dan Li
- Lin Yang
- Shao-ping Huang
- DOI
- https://doi.org/10.4103/1673-5374.155434
- Journal volume & issue
-
Vol. 10,
no. 4
pp. 599 – 604
Abstract
Previous studies have shown that the long-term use of antiepileptic drugs can cause nervous system damage. However, short-term antiepileptic drug treatment is frequently given to infants, especially neonates, to control seizure. Whether the short-term use of antiepileptic drugs is neurotoxic remains unclear. In the present study, immature rats, 3-21 days of age, were intraperitoneally injected with phenobarbital and/or topiramate for 3 consecutive days. Hematoxylin-eosin and immunohistochemical staining revealed that phenobarbital and topiramate, individually or in combination, were cytotoxic to hippocampal CA1 neurons and inhibited the expression of GluR1 and NR2B, excitatory glutamate receptor subunits. Furthermore, the combination of the two drugs caused greater damage than either drug alone. The results demonstrate that the short-term use of antiepileptic drugs damages neurons in the immature brain and that the combined use of antiepileptic drugs exacerbates damage. Our findings suggest that clinicians should consider the potential neurotoxic risk associated with the combined use of antiepileptic drugs in the treatment of seizure.
Keywords
- spinal cord injury
- propriospinal system
- neural plasticity
- fiber sprouting
- neural repair
- compensation
- regeneration
- propriospinal detours
- neurotrophic factors
- cell-adhesive ligands
- dorsal root ganglia
- L1CAM
- nerve growth factor
- biomaterials
- elastin-like proteins
- Alzheimer′s disease
- AMPK
- apoptosis
- autophagy
- central nervous system
- CCN4
- EGF
- diabetes mellitus
- erythropoietin
- EPO
- FGF
- IGF-1
- mTOR
- neuron
- neuropathy
- oxidative stress
- psychiatric
- stem cells
- WISP1
- Wnt
- peripheral nerve injury
- nerve graft
- nerve conduit
- Wallerian degeneration
- neurotrophic factors
- veins
- autografts
- nerve regeneration
- nerve regeneration
- neuroprotection
- resveratrol
- cerebral ischemia
- cerebral infarction
- matrix metalloproteinase
- molecular docking
- extracellular matrix
- neural regeneration
- nerve regeneration
- vagus nerve stimulation
- cerebral ischemia
- inflammatory cytokines
- infarct volume
- neurological function
- NSFC grants
- neural regeneration
- nerve regeneration
- Xingnao Kaiqiao needling method
- ischemic stroke
- randomized controlled trial
- systemic reviews
- meta-analysis
- long-term efficacy
- mortality
- recurrence
- disability
- adverse reactions
- health economics indicators
- neural regeneration
- nerve regeneration
- DDPH
- cerebral ischemia
- hippocampus
- blood flow
- isolated basilar artery
- dose-response curve
- NSFC grant
- neural regeneration
- nerve regeneration
- traumatic brain injury
- coma
- median nerve electrical stimulation
- wake-promoting
- orexin-A
- OX1R
- NSFC grants
- neural regeneration
- nerve regeneration
- seizure
- antiepileptic drugs
- immature brain
- hippocampus
- synaptic plasticity
- glutamate receptor
- NSFC grant
- neural regeneration